Patients with HIV-1 infection develop a broad spectrum of AIDS-associated malignancies including EBV+ and EBV- lymphomas, Kaposi's sarcoma, and other cancers such as basal cell carcinomas of skin and anogenital carcinomas. Fast evolving epidemiological and molecular analysis strongly suggest that EBV B cell lymphomas represent a significant proportion of more frequently occurring AIDS-associated malignancies. Although it can be argued that the pathogenesis of B cell neoplasms correlates solely to the immunodeficiency state, a mechanism can be proposed whereby an HIV protein acting with other cellular or viral co-factors, trans-activates an otherwise silent B cell growth factor gene(s). Excessive and aberrant production of such a B cell growth factor may lead to uncontrolled cell growth in the absence of EBV associated functions and c-myc translocations. This research is directed toward investigations of the interactions between viral and cellular genes in malignancies of B cell origin in HIV infected population. Emphasis will be placed on a T cell derived 12-kD human B cell growth factor, BCGF-12kD, and HIV trans-acting regulatory proteins including tat, nef, and vpr. The cDNA for BCGF-12kD has recently been identified in this laboratory (Sharma et al, Science 235:1481-1491, 1987). Our recent results strongly suggest that the BCGF-12kD gene is selectively expressed in EBV-B cell malignancies as compared to EBV transformed B cells and normal B cells. Furthermore, a mouse monoclonal antibody to BCGF-12kD synthetic peptide and BCGF-12kD anti-sense oligonucleotide inhibit the growth of EBV- malignant B cell lines as characterized by thymidine incorporation and the cellular growth. As a possible mechanism for the differential expression of the BCGF-12kD gene in EBV- B cell malignancies, we propose that interactions between the BCGF-12kD upstream regulatory regions and the transcription modulatory factors play an important role in development of malignancy. To that end, our recent results are of importance in that a specific binding to the BCGF-12kD upstream region is observed only with nuclear extract from EBV- malignant B cell lines. Therefore, a panel of EBV+ and EBV- B cell lines derived from non-AIDS lymphomas will be first used to establish the immunoregulatory role of BCGF-12kD by employing both immunological and molecular probes available to this laboratory. These studies will be expanded to include primary B cells or established B cell lines from AIDS patients. To investigate whether the tat protein trans-activates the BCGF-12kD promoter, the CAT assays will be done after transfecting a BCGF upstream regulatory region--CAT construct into constitutively Tat producing Hela or Jurkat cells. To test for the transforming activity, both the tat expression construct and the BCGF-12kD expression construct will be co-transfected into human B cells. It is anticipated that results generated in these studies should prove to be of vital importance to initiate the pathogenetic evaluation of B cell neoplasms in AIDS patients.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA054763-01
Application #
3199295
Study Section
Special Emphasis Panel (SRC (52))
Project Start
1991-03-08
Project End
1992-02-29
Budget Start
1991-03-08
Budget End
1992-02-29
Support Year
1
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Roger Williams Hospital
Department
Type
DUNS #
City
Providence
State
RI
Country
United States
Zip Code
02908
Chaouchi, N; Arvanitakis, L; Auffredou, M T et al. (1995) Characterization of transforming growth factor-beta 1 induced apoptosis in normal human B cells and lymphoma B cell lines. Oncogene 11:1615-22
Morgan, J W; Reddy, G S; Uskokovic, M R et al. (1994) Functional block for 1 alpha,25-dihydroxyvitamin D3-mediated gene regulation in human B lymphocytes. J Biol Chem 269:13437-43
Yaseen, N R; Park, J; Kerppola, T et al. (1994) A central role for Fos in human B- and T-cell NFAT (nuclear factor of activated T cells): an acidic region is required for in vitro assembly. Mol Cell Biol 14:6886-95
Newstein, M; Lee, I S; Venturini, D S et al. (1993) A chimeric human immunodeficiency virus type 1 TAR region which mediates high level trans-activation in both rodent and human cells. Virology 197:825-8
Yaseen, N R; Maizel, A L; Wang, F et al. (1993) Comparative analysis of NFAT (nuclear factor of activated T cells) complex in human T and B lymphocytes. J Biol Chem 268:14285-93
Fournier, S; Jackson, J; Kumar, A et al. (1992) Low-molecular weight B cell growth factor (BCGF-12KD) as an autocrine growth factor in B cell chronic lymphocytic leukemia. Eur J Immunol 22:1927-30
Kumar, A; Rogers, T; Maizel, A et al. (1991) Loss of transforming growth factor beta 1 receptors and its effects on the growth of EBV-transformed human B cells. J Immunol 147:998-1006
Vazquez, A; Auffredou, M T; Chaouchi, N et al. (1991) Differential inhibition of interleukin 2- and interleukin 4-mediated human B cell proliferation by ionomycin: a possible regulatory role for apoptosis. Eur J Immunol 21:2311-6